{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:36:28Z","timestamp":1791146188633,"version":"4.1.0"},"reference-count":35,"publisher":"Portland Press Ltd.","issue":"7","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,4,1]]},"abstract":"<jats:p>Chronic HCV (hepatitis C virus)-associated cirrhosis represents a major indication for liver transplantation. Bile acids contribute to hepatic stellate cell activation as a key event in fibrogenesis. The aim of the present study was to investigate the role of bile acids and polymorphisms in bile acid level-regulating genes on fibrosis progression. A total of 206 subjects with chronic HCV infection were included for ABCB11 (ATP-binding cassette, subfamily B, member II) 1331T&amp;gt;C and NR1H4 (nuclear receptor) \u22121G&amp;gt;T genotyping, 178 of which were analysed for fibrosis stage. Exclusion criteria were HBV (hepatitis B virus) or HIV coinfection, alcohol &amp;gt;40\u00a0g\/day and morbid obesity. A total of 358 patients with NAFLD (non-alcoholic fatty liver disease) were genotyped for comparison with a non-viral liver disease. Caucasian individuals (n = 110), undergoing liver resection for focal hepatic metastasis, served as controls. The ABCB11 1331C allele was significantly overrepresented in HCV patients compared with controls {allelic frequency 62.9%; OR (odds ratio), 1.41 [95% CI (confidence interval), 1.012\u20131.965]}. Median plasma bile acid levels were not significantly increased in the CC compared with TT genotype [7.2 (1\u2013110) \u03bcmol\/l compared with 3.5 (1\u201361) \u03bcmol\/l; values are medians (range). A significant association between the presence of cirrhosis and ABCB11 genotype (CC compared with CT or TT, P=0.047) was observed in the \u03c72 test and independent of other risk factors of age, gender, body mass index and disease duration in multivariate analysis (P = 0.010). No such association could be observed in fatty liver patients with regard to advanced fibrosis (F\u22652). The common ABCB11 1331CC genotype, which is present in 40% of HCV patients and renders the carrier susceptible to increased bile acid levels, is associated with cirrhosis.<\/jats:p>","DOI":"10.1042\/cs20100246","type":"journal-article","created":{"date-parts":[[2010,9,30]],"date-time":"2010-09-30T16:01:30Z","timestamp":1285862490000},"page":"287-296","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["A common polymorphism in the<i>ABCB11<\/i>gene is associated with advanced fibrosis in hepatitis C but not in non-alcoholic fatty liver disease"],"prefix":"10.1042","volume":"120","author":[{"given":"Rika","family":"Iwata","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Baur","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Stieger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Clinical Pharmacology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"},{"name":"Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, CH-8001 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim\u00a0C.","family":"Mertens","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann\u00a0K.","family":"Daly","sequence":"additional","affiliation":[{"name":"Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne NE2 4HH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Frei","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Braun","sequence":"additional","affiliation":[{"name":"Biostatistics Unit, Institute of Social und Preventive Medicine, University of Zurich, CH-8001 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Vergopoulos","sequence":"additional","affiliation":[{"name":"Institute for Clinical Chemistry, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Stickel","sequence":"additional","affiliation":[{"name":"Department of Visceral Surgery and Medicine, University of Bern, Inselspital, CH-3010 Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Sabrane","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ina\u00a0V.","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"},{"name":"\u2020Department of Internal Medicine II, Aachen University (RWTH), University Hospital (UKA), D-52074 Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Schmitt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Goetze","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris\u00a0P.","family":"Day","sequence":"additional","affiliation":[{"name":"Institute of Cellular Medicine, Newcastle University Medical School, Newcastle upon Tyne NE2 4HH, U.K."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"M\u00fcllhaupt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"},{"name":"\u00a7Swiss Hepatopancreatobiliary (HPB) Center, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Geier","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Gastroenterology and Hepatology, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"},{"name":"Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, CH-8001 Zurich, Switzerland"},{"name":"\u00a7Swiss Hepatopancreatobiliary (HPB) Center, University Hospital Zurich (USZ), CH-8091 Zurich, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Swiss Hepatitis C Cohort Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2010,12,13]]},"reference":[{"key":"2021113010180012100_B1","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(03)15109-4","article-title":"Viral hepatitis C","volume":"362","author":"Poynard","year":"2003","journal-title":"Lancet"},{"key":"2021113010180012100_B2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1089-3261(02)00078-8","article-title":"Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002","volume":"7","author":"Seeff","year":"2003","journal-title":"Clin. Liver Dis."},{"key":"2021113010180012100_B3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0140-6736(96)07642-8","article-title":"Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups","volume":"349","author":"Poynard","year":"1997","journal-title":"Lancet"},{"key":"2021113010180012100_B4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/hep.21459","article-title":"Hepatic fibrosis 2006: report of the Third AASLD Single Topic Conference","volume":"45","author":"Friedman","year":"2007","journal-title":"Hepatology"},{"key":"2021113010180012100_B5","doi-asserted-by":"crossref","first-page":"S194","DOI":"10.1002\/hep.21065","article-title":"Hepatitis C: identifying patients with progressive liver injury","volume":"43","author":"Feld","year":"2006","journal-title":"Hepatology"},{"key":"2021113010180012100_B6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"2021113010180012100_B7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/jhep.2003.50127","article-title":"Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal","volume":"37","author":"Bataller","year":"2003","journal-title":"Hepatology"},{"key":"2021113010180012100_B8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.21695","article-title":"A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C","volume":"46","author":"Huang","year":"2007","journal-title":"Hepatology"},{"key":"2021113010180012100_B9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/ije\/dym096","article-title":"Cohort Profile: the Swiss Hepatitis C Cohort Study (SCCS)","volume":"36","author":"Prasad","year":"2007","journal-title":"Int. J. Epidemiol."},{"key":"2021113010180012100_B10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/hep.22637","article-title":"Fibrogenesis in pediatric cholestatic liver disease: role of taurocholate and hepatocytes-derived monocyte chemotaxis protein-1 in hepatic stellate cell recruitment","volume":"49","author":"Ramm","year":"2009","journal-title":"Hepatology"},{"key":"2021113010180012100_B11","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00424-006-0152-8","article-title":"The bile salt export pump","volume":"453","author":"Stieger","year":"2007","journal-title":"Pflugers Arch."},{"key":"2021113010180012100_B12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/hep.21214","article-title":"Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver","volume":"44","author":"Meier","year":"2006","journal-title":"Hepatology"},{"key":"2021113010180012100_B13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3748\/wjg.14.38","article-title":"Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T&gt;C polymorphism in the bile salt export pump","volume":"14","author":"Meier","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"2021113010180012100_B14","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1210\/me.2007-0025","article-title":"A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression","volume":"21","author":"Marzolini","year":"2007","journal-title":"Mol. Endocrinol."},{"key":"2021113010180012100_B15","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1053\/j.gastro.2007.05.015","article-title":"Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy","volume":"133","author":"Van\u00a0Mil","year":"2007","journal-title":"Gastroenterology"},{"key":"2021113010180012100_B16","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2008.04.004","article-title":"The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease","volume":"135","author":"Miele","year":"2008","journal-title":"Gastroenterology"},{"key":"2021113010180012100_B17","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"2021113010180012100_B18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jhep.2007.07.027","article-title":"Variation of the gene encoding the nuclear bile salt receptor FXR and gallstone susceptibility in mice and humans","volume":"48","author":"Kovacs","year":"2008","journal-title":"J. Hepatol."},{"key":"2021113010180012100_B19","first-page":"193","article-title":"Genotyping for cytochrome P450 polymorphisms","volume":"320","author":"Daly","year":"2006","journal-title":"Methods Mol. Biol."},{"key":"2021113010180012100_B20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","article-title":"Power and sample size calculations. A review and computer program","volume":"11","author":"Dupont","year":"1990","journal-title":"Control Clin. Trials"},{"key":"2021113010180012100_B21","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/hep.21359","article-title":"Hepatobiliary transporters and drug-induced cholestasis","volume":"44","author":"Pauli-Magnus","year":"2006","journal-title":"Hepatology"},{"key":"2021113010180012100_B22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/gut.2008.159541","article-title":"Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy","volume":"58","author":"Dixon","year":"2008","journal-title":"Gut"},{"key":"2021113010180012100_B23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.22683","article-title":"Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing","volume":"49","author":"Byrne","year":"2009","journal-title":"Hepatology"},{"key":"2021113010180012100_B24","doi-asserted-by":"crossref","first-page":"21805","DOI":"10.1074\/jbc.C000275200","article-title":"Bile acid induction of cytokine expression by macrophages correlates with repression of hepatic cholesterol 7\u03b1-hydroxylase","volume":"275","author":"Miyake","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021113010180012100_B25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/01.fpc.0000230418.28091.76","article-title":"Mutations and polymorphisms in the bile salt export pump and the multidrug resistance protein 3 associated with drug-induced liver injury","volume":"17","author":"Lang","year":"2007","journal-title":"Pharmacogenet. Genomics"},{"key":"2021113010180012100_B26","article-title":"The role of bile acid retention and a common polymorphism in the ABCB11 gene as host factors affecting antiviral treatment response in chronic hepatitis C. J. Viral Hepatol.","author":"Iwata","year":"2010"},{"key":"2021113010180012100_B27","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1053\/jhep.2003.09022","article-title":"Sampling variability of liver fibrosis in chronic hepatitis C","volume":"38","author":"Bedossa","year":"2003","journal-title":"Hepatology"},{"key":"2021113010180012100_B28","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"2021113010180012100_B29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis","volume":"41","author":"Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"2021113010180012100_B30","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1053\/j.gastro.2005.09.009","article-title":"Bile acid synthesis in humans has a rapid diurnal variation that is asynchronous with cholesterol synthesis","volume":"129","author":"Galman","year":"2005","journal-title":"Gastroenterology"},{"key":"2021113010180012100_B31","first-page":"CD003181","article-title":"Bile acids for viral hepatitis","volume":"4","author":"Chen","year":"2007","journal-title":"Cochrane Database Syst Rev."},{"key":"2021113010180012100_B32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0168-8278(05)80558-6","article-title":"Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial","volume":"19","author":"Bellentani","year":"1993","journal-title":"J. Hepatol."},{"key":"2021113010180012100_B33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00042737-200012050-00006","article-title":"Efficacy of ursodeoxycholic acid in association with \u03b1-interferon for chronic hepatitis C in \u03b1-interferon non-responder patients","volume":"12","author":"Fabbri","year":"2000","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"2021113010180012100_B34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1158\/1055-9965.164.14.1","article-title":"Ursodiol use is possibly associated with lower incidence of hepatocellular carcinoma in hepatitis C virus-associated liver cirrhosis","volume":"14","author":"Tarao","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"2021113010180012100_B35","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/hep.510290617","article-title":"Bile acids modulate the interferon signalling pathway","volume":"29","author":"Podevin","year":"1999","journal-title":"Hepatology"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/120\/7\/287\/442097\/cs1200287.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/120\/7\/287\/442097\/cs1200287.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,3]],"date-time":"2023-06-03T15:08:59Z","timestamp":1685804939000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/120\/7\/287\/68867\/A-common-polymorphism-in-the-ABCB11-gene-is"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12,13]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20100246","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12,13]]}}}